An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria. - De A; Pal S; Singh S; Chakroborty D; Godse K (Indian journal of dermatology, 2024)